|
GlaxoSmithKline Pharmaceuticals Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
52624.29 Cr.
|
P/BV
|
21.01
|
Book Value (Rs.)
|
147.85
|
|
52 Week High/Low (Rs.)
|
3121/2088
|
FV/ML
|
10/1
|
P/E(X)
|
50.80
|
|
Bookclosure
|
29/05/2026
|
EPS (Rs.)
|
61.15
|
Div Yield (%)
|
1.83
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 2036.56 | 1785.11 | 1923.79 | 1825.42 | 1735.06 |
| Total Income From Operations | 2036.56 | 1785.11 | 1923.79 | 1825.42 | 1735.06 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 192.96 | 243.19 | 212.71 | 287.19 | 295.55 |
| Purchase of Traded Goods | 445.67 | 464.78 | 455.63 | 389.48 | 418.26 |
| Increase/Decrease in Stocks | 69.19 | -64.73 | 42.76 | 3.09 | -29.84 |
| Employees Cost | 316.63 | 290.62 | 277.71 | 301.99 | 314.18 |
| Depreciation | 33.49 | 32.95 | 33.52 | 33.27 | 35.21 |
| Other Expenses | 289.84 | 264.32 | 309.87 | 291.42 | 261.59 |
| Total Expenses | 1347.78 | 1231.13 | 1332.20 | 1306.44 | 1294.95 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 688.78 | 553.98 | 591.59 | 518.98 | 440.11 |
| Other Income | 68.07 | 77.29 | 75.75 | 70.18 | 57.94 |
| P/L Before Interest, Excpt. Items & Tax | 756.85 | 631.27 | 667.34 | 589.16 | 498.05 |
| Interest | 1.80 | 0.93 | 0.67 | 0.64 | 1.09 |
| P/L Before Exceptional Items & Tax | 755.05 | 630.34 | 666.67 | 588.52 | 496.96 |
| Exceptional Items | 17.98 | 2.64 | 0.00 | 4.69 | -160.91 |
| P/L Before Tax | 773.03 | 632.98 | 666.67 | 593.21 | 336.05 |
| Tax | 199.55 | 170.48 | 173.92 | 158.38 | 95.85 |
| P/L After Tax from Ordinary Activities | 573.48 | 462.50 | 492.75 | 434.83 | 240.20 |
| Net Profit/Loss For the Period | 573.48 | 462.50 | 492.75 | 434.83 | 240.20 |
| Net P/L After Minority Interest & Share Of Associates | 573.48 | 462.50 | 492.75 | 434.83 | 240.20 |
| | | | | | |
| Equity Share Capital | 169.41 | 169.41 | 169.41 | 169.41 | 169.41 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 33.85 | 27.30 | 29.09 | 25.67 | 14.18 |
| Diluted EPS (Rs.) | 33.85 | 27.30 | 29.09 | 25.67 | 14.18 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 33.85 | 27.30 | 29.09 | 25.67 | 14.18 |
| Diluted EPS (Rs.) | 33.85 | 27.30 | 29.09 | 25.67 | 14.18 |
| | | | | | |
| PBITOE Margin (%) | 33.82 | 31.03 | 30.75 | 28.43 | 25.36 |
| PBTE Margin (%) | 37.07 | 35.31 | 34.65 | 32.24 | 28.64 |
| PBT Margin (%) | 37.95 | 35.45 | 34.65 | 32.49 | 19.36 |
| PAT Margin (%) | 28.15 | 25.90 | 25.61 | 23.82 | 13.84 |
| PAT After MI And SOA Margin (%) | 28.15 | 25.90 | 25.61 | 23.82 | 13.84 |
